Malin Löwenmark

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Timsina, Jigyasha; Jiang, Chenyang; McCartney, Daniel L.; Tao, Feifei et al.

Ingår i Nature Communications, 2026

• DOI för GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy
• Ladda ner fulltext (pdf) av GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Hofling, Ulrika; Jakobsson, Jenny; Erngren, Ida; Ekman, Oskar et al.

Ingår i Fluids and Barriers of the CNS, 2026

• DOI för Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Nicolas, Aude; Sherva, Richard; Grenier-Boley, Benjamin; Kim, Yoontae et al.

Ingår i Nature Genetics, 2025

• DOI för Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
• Ladda ner fulltext (pdf) av Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Georgiopoulos, Charalampos; Papadimitriou, Stergios; Nyholm, Dag; Kilander, Lena et al.

Ingår i Journal of Neuroimaging, s. 612-618, 2024

• DOI för Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

Kallström, Angelica; Giedraitis, Vilmantas; Franzon, Kristin; Löwenmark, Malin et al.

Ingår i International Journal of Geriatric Psychiatry, 2024

• DOI för Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men
• Ladda ner fulltext (pdf) av Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Timsina, Jigyasha; Jiang, Chenyang; McCartney, Daniel L.; Tao, Feifei et al.

Ingår i Nature Communications, 2026

• DOI för GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy
• Ladda ner fulltext (pdf) av GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy

Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Hofling, Ulrika; Jakobsson, Jenny; Erngren, Ida; Ekman, Oskar et al.

Ingår i Fluids and Barriers of the CNS, 2026

• DOI för Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Nicolas, Aude; Sherva, Richard; Grenier-Boley, Benjamin; Kim, Yoontae et al.

Ingår i Nature Genetics, 2025

• DOI för Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
• Ladda ner fulltext (pdf) av Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations

Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Georgiopoulos, Charalampos; Papadimitriou, Stergios; Nyholm, Dag; Kilander, Lena et al.

Ingår i Journal of Neuroimaging, s. 612-618, 2024

• DOI för Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

Kallström, Angelica; Giedraitis, Vilmantas; Franzon, Kristin; Löwenmark, Malin et al.

Ingår i International Journal of Geriatric Psychiatry, 2024

• DOI för Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men
• Ladda ner fulltext (pdf) av Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Braun, Madelen; Boström, Gustaf; Ingelsson, Martin; Kilander, Lena et al.

Ingår i Fluids and Barriers of the CNS, 2023

• DOI för Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
• Ladda ner fulltext (pdf) av Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Feasibility of PURPOSE T in clinical practice and patient participation: a mixed-method study

Hultin, Lisa; Karlsson, Ann-Christin; Löwenmark, Malin; Coleman, Susanne et al.

Ingår i International Wound Journal, s. 633-647, 2023

• DOI för Feasibility of PURPOSE T in clinical practice and patient participation: a mixed-method study
• Ladda ner fulltext (pdf) av Feasibility of PURPOSE T in clinical practice and patient participation: a mixed-method study

Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia

Pagnon de la Vega, María; Näslund, Carl; Brundin, RoseMarie; Lannfelt, Lars et al.

Ingår i BMC Genomics, 2022

• DOI för Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
• Ladda ner fulltext (pdf) av Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia

The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

de la Vega, Maria Pagnon; Giedraitis, Vilmantas; Michno, Wojciech; Kilander, Lena et al.

Ingår i Science Translational Medicine, 2021

• DOI för The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

Fällmar, David; Andersson, Oliver; Kilander, Lena; Löwenmark, Malin et al.

Ingår i Fluids and Barriers of the CNS, 2021

• DOI för Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
• Ladda ner fulltext (pdf) av Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

Boström, Gustaf; Freyhult, Eva; Virhammar, Johan; Alcolea, Daniel et al.

Ingår i Journal of Alzheimer's Disease, s. 629-640, 2021

• DOI för Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid
• Ladda ner fulltext (pdf) av Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

Bergström, Sofia; Remnestål, Julia; Yousef, Jamil; Olofsson, Jennie et al.

Ingår i Annals of Clinical and Translational Neurology, s. 1456-1470, 2021

• DOI för Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
• Ladda ner fulltext (pdf) av Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

Emami Khoonsari, Payam; Shevchenko, Ganna; Herman, Stephanie; Remnestal, Julia et al.

Ingår i Journal of Alzheimer's Disease, s. 639-651, 2019

• DOI för Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
• Ladda ner fulltext (pdf) av Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease

Gunnarsson, Malin Degerman; Ingelsson, Martin; Blennow, Kaj; Basun, Hans et al.

Ingår i Alzheimer's Research & Therapy, 2016

• DOI för High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
• Ladda ner fulltext (pdf) av High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease

High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease

Degerman Gunnarsson, Malin; Lannfelt, Lars; Ingelsson, Martin; Basun, Hans et al.

Ingår i Dementia and Geriatric Cognitive Disorders, s. 196-206, 2014

• DOI för High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease

Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography

Degerman Gunnarsson, Malin; Lindau, M; Santillo, A F; Wall, Anders et al.

Ingår i Dementia and Geriatric Cognitive Disorders Extra, s. 472-481, 2013

• DOI för Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography

CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid

Giedraitis, Vilmantas; Glaser, Anna; Sarajärvi, Timo; Brundin, RoseMarie et al.

Ingår i Neuroscience Letters, s. 265-267, 2010

• DOI för CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Degerman Gunnarsson, Malin; Lindau, Maria; Wall, Anders; Blennow, K et al.

Ingår i Dementia and Geriatric Cognitive Disorders, s. 204-212, 2010

• DOI för Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Oligomerization partially explains the lowering of Aβ42 in Alzheimer's disease cerebrospinal fluid

Englund, Hillevi; Degerman Gunnarsson, Malin; Brundin, RoseMarie; Hedlund, Marie et al.

Ingår i Neuro-degenerative diseases, s. 139-147, 2009

• DOI för Oligomerization partially explains the lowering of Aβ42 in Alzheimer's disease cerebrospinal fluid

Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study

Sundelöf, Johan; Giedraitis, Vilmantas; Irizarry, Michael C; Sundström, Johan et al.

Ingår i Archives of Neurology, s. 256-63, 2008

• DOI för Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study

Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer's Disease

Degerman Gunnarsson, Malin; Kilander, Lena; Basun, Hans; Lannfelt, Lars

Ingår i Dementia and Geriatric Cognitive Disorders, s. 247-252, 2007

• DOI för Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer's Disease

Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease

Degerman Gunnarsson, Malin

2013

• Ladda ner fulltext (pdf) av Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease